Discovery of Benzisothiazolone Derivatives as Bifunctional Inhibitors of HIV-1 Reverse Transcriptase DNA Polymerase and Ribonuclease H Activities
Biomolecules · 2024
DOI: 10.3390/biom14070819 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2024. Verfasst von Alondra Vázquez Rivera und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA. Hauptthemen laut MEDLINE: HIV Reverse Transcriptase, Reverse Transcriptase Inhibitors, HIV-1, Thiazoles. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, National Institutes of Health, Molecular Library Screening Center Network.
Abstract (Originalsprache)
The ribonuclease H (RNase H) active site of HIV-1 reverse transcriptase (RT) is the only viral enzyme not targeted by approved antiretroviral drugs. Using a fluorescence-based in vitro assay, we screened 65,239 compounds at a final concentration of 10 µM to identify inhibitors of RT RNase H activity. We identified 41 compounds that exhibited 50% inhibitory concentration (i.e., IC50) values < 1.0 µM. Two of these compounds, 2-(4-methyl-3-(piperidin-1-ylsulfonyl)phenyl)benzo[d]isothiazol-3(2H)-one (1) and ethyl 2-(2-(3-oxobenzo[d]isothiazol-2(3H)-yl)thiazol-4-yl)acetate (2), which both share the same benzisothiazolone pharmacophore, demonstrate robust antiviral activity (50% effective concentrations of 1.68 ± 0.94 µM and 2.68 ± 0.54, respectively) in the absence of cellular toxicity. A limited structure–activity relationship analysis identified two additional benzisothiazolone analogs, 2-methylbenzo[d]isothiazol-3(2H)-one (3) and N,N-diethyl-3-(3-oxobenzo[d]isothiazol-2(3H)-yl)benzenesulfonamide (4), which also resulted in the inhibition of RT RNase H activity and virus replication. Compounds 1, 2 and 4, but not 3, inhibited the DNA polymerase activity of RT (IC50 values~1 to 6 µM). In conclusion, benzisothiazolone derivatives represent a new class of multifunctional RT inhibitors that warrants further assessment for the treatment of HIV-1 infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
- Department of Chemical Biology and Pharmacology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
- Department of Pharmacology, University of Virginia, Charlottesville, VA 22908, USA.
- Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA.
- Department of Pharmaceutical Sciences, University of Pittsburgh School of Pharmacy, Pittsburgh, PA 15261, USA.
ORCID-Profile: John S Lazo
Förderung
- NCI NIH HHS
- NIH HHS
- National Institutes of Health, Molecular Library Screening Center Network
Zitieren
APA
Vázquez Rivera, A., Donald, H., Alaoui-El-Azher, M., Skoko, J. J., Lazo, J. S., Parniak, M. A., Johnston, P. A., & Sluis-Cremer, N. (2024). Discovery of Benzisothiazolone Derivatives as Bifunctional Inhibitors of HIV-1 Reverse Transcriptase DNA Polymerase and Ribonuclease H Activities. Biomolecules. https://doi.org/10.3390/biom14070819
Vancouver
Vázquez Rivera A, Donald H, Alaoui-El-Azher M, Skoko JJ, Lazo JS, Parniak MA, et al. Discovery of Benzisothiazolone Derivatives as Bifunctional Inhibitors of HIV-1 Reverse Transcriptase DNA Polymerase and Ribonuclease H Activities. Biomolecules. 2024. doi:10.3390/biom14070819
BibTeX
@article{VzquezRivera2024,
author = {Vázquez Rivera, Alondra and Donald, Heather and Alaoui-El-Azher, Mounia and Skoko, John J and Lazo, John S and Parniak, Michael A and Johnston, Paul A and Sluis-Cremer, Nicolas},
title = {Discovery of Benzisothiazolone Derivatives as Bifunctional Inhibitors of HIV-1 Reverse Transcriptase DNA Polymerase and Ribonuclease H Activities},
journal = {Biomolecules},
year = {2024},
doi = {10.3390/biom14070819}
}
EUVIMED